Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings - Reuters
Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQYkk0cFdtOFRtV0JRVF9lZE5IelR1dTRjZDVuNm9mRGJTTklPUEhGSThfc3djZkpqZVUxeGV6ZGM2c0xTd0Mxb0sxZWZVcGlCS0NqREJwX09kTFNzWjliVlBNR245XzNrUnhmZktqdmgzOXE2M2dVQVVYM3d5S1NCUVI4aUpxbEQ5eDd5TlBhMnQ3ZUQzN0ZVdmJ2ckkzR1gzODRpTU51QkJ5dlpyN201NVpwN1VBQm4wRXpObnFiZFVYZVdwZmY0?oc=5" target="_blank">Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial - Reuters
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Reuters
August 27, 2026 at 06:10 AMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMUS FDA approves Takeda, Protagonist's drug for rare blood cancer - Reuters
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
August 28, 2026 at 10:16 PMBioNTech halts mRNA colorectal cancer vaccine trial after safety review - Reuters
BioNTech halts mRNA colorectal cancer vaccine trial after safety review Reuters
August 28, 2026 at 05:12 PMUS FDA approves Roivant-Priovant's skin and muscle disease drug - Reuters
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
August 27, 2026 at 10:42 PMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PM